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Longitudinal EEG power in the first postnatal year
differentiates autism outcomes
Laurel J. Gabard-Durnam1, Carol Wilkinson1, Kush Kapur2, Helen Tager-Flusberg3, April R. Levin1,2 &
Charles A. Nelson1,4,5
An aim of autism spectrum disorder (ASD) research is to identify early biomarkers that
inform ASD pathophysiology and expedite detection. Brain oscillations captured in electro-
encephalography (EEG) are thought to be disrupted as core ASD pathophysiology.
We leverage longitudinal EEG power measurements from 3 to 36 months of age in infants at
low- and high-risk for ASD to test how and when power distinguishes ASD risk and diagnosis
by age 3-years. Power trajectories across the first year, second year, or first three years
postnatally were submitted to data-driven modeling to differentiate ASD outcomes. Power
dynamics during the first postnatal year best differentiate ASD diagnoses. Delta and gamma
frequency power trajectories consistently distinguish infants with ASD diagnoses from oth-
ers. There is also a developmental shift across timescales towards including higher-frequency
power to differentiate outcomes. These findings reveal the importance of developmental
timing and trajectory in understanding pathophysiology and classifying ASD outcomes.
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Autism spectrum disorder (ASD) is a prevalent neurodeve-lopmental disorder that currently affects 1 out of 40 chil-dren1. Early identification and intervention is critical to
improve outcomes for those with ASD, but overt behavioral
symptoms of ASD generally only begin to manifest across the
second year after birth2–5. Thus, there is a need for more sensitive
physiological indicators of ASD that can be identified earlier in
development5,6. As brain pathophysiology gives rise to the beha-
vioral symptoms of ASD, measuring neurophysiology across the
first years after birth facilitates detecting early biomarkers of sub-
sequent ASD diagnosis that can expedite detection and treatment,
and provide biological targets for novel interventions7,8.
An emerging literature suggests that early disruptions in the
brain’s oscillatory rhythms are core neural features of ASD patho-
physiology. These rhythms are captured by electroencephalographic
(EEG) activity. Accordingly, many differences have been noted
between groups at elevated risk for ASD or with ASD outcomes
across a variety of EEG-derived oscillatory measures, including
spectral power9–12. In particular, differences between ASD risk
groups in EEG spectral power across a range of frequency bands
over the frontal cortex have been shown to emerge early in infancy
and relate to later symptomatology9–16. Infants with elevated risk of
ASD have been shown to have lower frontal alpha and beta band
power at 3 months of age, lower frontal power from delta through
gamma frequency bands by 6 months of age, and different age-
related changes in delta, alpha, beta, and gamma band power
through two years of age, showing largely steeper age-related
increases in power9–11. Compared to other cortical regions, frontal
EEG power consistently demonstrates differences in theta, alpha,
and gamma bands during the second year postnatally that have
been associated with a range of ASD symptom domains in this
elevated-risk population, including sensory hyporesponsiveness,
cognitive deficits, language, and the degree of restricted and repe-
titive behaviors9,10,12–16. However, it remains to be determined
how well early EEG differences can distinguish subsequent ASD
outcomes.
Importantly, longitudinal studies have found significant
developmental changes in frontal EEG power in all frequency
bands across the first years after birth9,10,13. Thus, the capacity for
EEG power to differentiate ASD outcomes and the integrity of
individual EEG power measures may change across this period8.
These critical factors have yet to be tested. Moreover, develop-
mental changes in EEG power may themselves constitute diag-
nostic measures (e.g., 17–19), but no study to date has tested
whether EEG trajectories over development may be leveraged for
differentiating ASD outcomes. Longitudinal comparisons are
needed to determine when EEG power is most useful for differ-
entiating ASD outcomes, and how candidate EEG power bio-
markers change across early neurodevelopment.
The present study seeks to determine the EEG power patho-
physiology over the first three postnatal years that differentiates
subsequent ASD risk and diagnostic outcomes. High-risk popula-
tions that have elevated ASD incidence, such as infant siblings of
children with ASD, facilitate prospective testing for early patho-
physiology in ASD4,5. Here, we leverage longitudinal baseline EEG
in a cohort of these high familial risk infant siblings and infants at
low familial risk for ASD to derive data-driven profiles of EEG
power across multiple timescales. Given the robust early differences
observed over frontal cortex, the present study focuses a priori on
frontal EEG power to address this question. We focus on frontal
EEG pathophysiology across three key developmental windows: the
first year, antecedent to behavioral symptoms; the second year,
concurrent with emerging behavioral symptoms; and the three year
period including the age of confirmed ASD diagnosis. We first
assess the performance of EEG power measures across develop-
mental windows to determine which period of time best
differentiates ASD risk and diagnostic outcomes within our sam-
ple. We also perform supplemental analyses comparing frontal
cortex EEG to whole-head coverage and temporal-parietal spatial
configurations to test for spatial specificity in differentiation effects.
Finally, we identify which EEG frequency bands and their devel-
opmental trajectories differentiate groups as potential diagnostic
biomarkers, and whether these measures’ identities change across
the three developmental windows. In these ways, we aim to illu-
minate the EEG power measures and developmental timing that
provide the most robust differentiation of ASD risk and diagnoses.
Results
Data-driven models of EEG power differentiate ASD outcomes.
To determine when across the first three years after birth EEG
power measures best differentiate ASD risk and outcome groups
within this sample, a series of logistic regression models were
constructed. These logistic regression models differentiated
groups (ASD vs. HRA−, ASD vs. LRC, and HRA− vs. LRC)
using longitudinal EEG parameters from three developmental
windows: 3–12 months, 12–24 months, and 3–36 months (Fig. 1,
Table 1)). For each group comparison in each developmental
window, the EEG power intercepts and developmental slope
variables for each frequency band were potential model para-
meters. Data-driven model construction selected the set of EEG
power parameters that best differentiated each pair of groups over
each developmental window. Parental education and participant
sex were included as covariates for each analysis. First, model
performance was compared across the different developmental
windows to identify the time period that best differentiated risk
and outcome groups. The models constructed with frontal EEG
were also compared to models using different spatial layouts
(whole-head coverage and temporal-parietal channels; Table 1,
Supplementary Tables 1–6). Finally, the selected EEG power
parameters and their significance within each model were com-
pared to identify candidate longitudinal power biomarkers across
the different developmental windows.
We first compared how well the different data-driven models
performed at differentiating groups across developmental win-
dows by assessing receiver operating characteristic (ROC) curves
for the models. Notably, all models tested significantly differ-
entiated each pair of groups (all area under the curve (AUC)
bootstrapped confidence interval (CI95) lower bounds >0.5, Fig. 1,
Table 1). Comparisons of model performance are organized
below by those discriminating children with ASD diagnoses from
others (ASD vs. HRA−, ASD vs. LRC) across timescales, and
those discriminating children with differential ASD risk in the
absence of ASD (HRA− vs. LRC) across timescales.
ASD diagnostic outcome discrimination across development.
Across developmental windows and spatial topographies, the
frontal 3–12 month EEG models most accurately discriminated
the ASD group from the other groups (Table 1). These
3–12 month models also had higher specificity rates and rates
predicting true positive ASD outcomes (positive predictive values
(PPV)) than the other frontal models, as well as higher or com-
parable rates predicting true negative ASD outcomes (e.g., for the
model distinguishing ASD from HRA− infants, frontal
3–12 month negative predictive value of 91.67 vs. 92.98 for the
3–36 month model; Table 1). No frontal EEG model consistently
outperformed others with respect to sensitivity rates in the pri-
mary analyses, and all models achieved high sensitivity rates. As
more infants contributed data to the frontal 3–36 month models
than the frontal 3–12 month models, secondary analyses modeled
a restricted 3-year subsample of the same infants from the
3–12 month analysis. However, the frontal 3–12 month models
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remained the most accurate at differentiating those with ASD
diagnoses from others.
ASD-risk discrimination across development. Across develop-
mental windows and spatial topographies, the frontal
3–36 month EEG model most accurately discriminated the high-
risk from low-risk groups in the absence of ASD (Table 1). The
frontal 3–36 month model also had higher optimized specificity
rates and rates predicting true high-risk status, but lower sen-
sitivity rates and rates predicting true low-risk status than the
other windows of frontal EEG power (Table 1). The risk-
discrimination models achieved poorer discrimination accuracy,
sensitivity, specificity, and true negative prediction rates than
the corresponding ASD outcome discrimination models over all
developmental windows.
Identification of EEG power candidate biomarkers. Next, to
assess which frontal EEG power measures differentiated these
ASD groups across developmental timescales as potential bio-
markers, the EEG power parameters that the data-driven model
construction process had selected were examined for each group
comparison across each developmental window (Tables 2–4;
whole-head and temporal-parietal model parameters provided in
Supplementary Tables 1–6). EEG power for a given frequency
band in these models reflects the summed power across all fre-
quencies within that frequency band (summed power). Para-
meters within each model were also evaluated to identify
significant individual outcome discriminators. With regard to the
participant sex and parental education covariates modeled, par-
ticipant sex was not a significant measure in any model at any
age. The parental education covariate was included in many
models differentiating the LRC infants from others, but in the
majority of comparisons, only the parameter differentiating
parents with 4-year college degrees from those with further
education was significant (education parameter 2). Supplemental
analyses without the sex and education covariates returned
similar results to the analyses that included these covariates.
Comparisons for each developmental window are organized by
those discriminating children with ASD diagnoses from others
(ASD vs. HRA−, ASD vs. LRC) and those discriminating children
in both high-risk groups relative to the low-risk children (i.e.,
high-risk markers, ASD vs. LRC and HRA− vs. LRC). All sig-
nificance tests of individual model parameters refer to Student’s
t tests performed within the multiple logistic regression model
(i.e., including all other model parameters simultaneously).
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Fig. 1 ROC curves. Receiver operating characteristic (ROC) curves for each frontal EEG model comparing pairs of ASD outcome groups for each
developmental window (a–d). Area under the curve and their 95% confidence intervals are given in the right corner of each ROC curve. Dashed black lines
indicate chance performance. Solid black line indicates each model’s performance
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Frontal EEG candidate biomarkers from 3–12 months. Across
models in this window, low frequency bands were significant
individual parameters differentiating ASD outcomes (Table 2).
Higher frequency bands, beta and gamma, were only selected in
data-driven models differentiating ASD infants from others, such
that lower levels of high-frequency power at age 6 months
increased the log-odds of the child having ASD over and above
the other selected frequency band parameters (e.g. beta power
intercept, Student’s t test p= 0.022). Delta and theta slopes
during this period were significant individual indicators of high-
risk for ASD (ASD and HRA−) relative to LRC status, with
steeper delta and less-steep theta slopes over the first postnatal
year increasing the log-odds of the child belonging to the high-
risk groups in the context of the other selected frequency band
parameters (ASD: delta slope Student’s t test p= 0.006, theta
interaction Student’s t test p= 0.013; HRA−: delta slope Stu-
dent’s t-test p= 0.022, theta slope Student’s t test p= 0.003).
Frontal EEG candidate biomarkers from 12–24 months. Across
second-year models, significant EEG parameters occurred at
higher frequencies than in the 3–12 month models (Table 3). Beta
frequency predictors were only selected in models differentiating
the ASD children from others. Lower summed power in beta
band at 12 months of age increased the log-odds of the child
having ASD in the context of the other selected frequency band
parameters (Student’s t test p= 0.016). Steeper slopes in beta
power over the second postnatal year as a function of beta power
at 12 months of age also increased the log-odds of the child
having ASD within the high-risk group over and above the other
selected frequency band parameters (Student’s t test p= 0.033).
Frontal EEG candidate biomarkers from 3 to 36 months.
Higher frequencies were significant individual parameters relative
to those in earlier windows (Table 4). Low alpha and gamma
developmental slopes across 3 years were unique significant indi-
cators of ASD diagnosis. Less steep increases in low alpha summed
power from 3 to 36 months of age increased the log-odds of the
child having ASD within the high-risk group, and the summed
power in low alpha at 6 months of age interacted differently with
the increase in low alpha power during this window to increase the
log-odds of the child having ASD in the context of the other
selected frequency band parameters (vs. HRA−: slope Student’s
Table 1 Model performance metrics discriminating autism groups
Models Discrimination rate (CI95) Sensitivity† Specificity† PPV NPV
3–12 months
Frontal
ASD vs. HRA- 89.1% (81.2–97.1%) 81.82 86.27 72 91.67
ASD vs. LRC 91.0% (83.2–98.8%) 82.35 87.72 66.67 94.34
HRA- vs. LRC 76.7% (67.7–85.7%) 81.25 61.4 63.93 79.55
Whole-head
ASD vs. HRA− 81.7% (70.0–93.5%) 90.91 64.71 52.63 94.29
ASD vs. LRC 80.3% (65.9–94.7%) 76.47 80.7 54.17 92
HRA− vs. LRC 73.9% (64.6–83.3%) 54.17 82.46 72.22 68.12
Temporal-Parietal
ASD vs. HRA− 83.4% (72.9–93.9%) 72.73 86.27 69.57 88
ASD vs. LRC 82.2% (68.7–95.8%) 64.71 96.49 84.62 90.16
HRA- vs. LRC 77.4% (68.6–86.3%) 64.58 78.95 72.09 72.58
12–24 months
Frontal
ASD vs. HRA− 81.7% (71.6–91.8%) 80 75.56 64.52 87.18
ASD vs. LRC 86.4% (76.0–96.8%) 90 70.45 58.06 93.94
HRA− vs. LRC 74.8% (65.0–84.7%) 77.78 70 70 77.78
Whole-head
ASD vs. HRA- 87.6% (78.8–96.5%) 70 93.48 82.35 87.76
ASD vs. LRC 89.0% (78.9–99.1%) 85 87.5 73.91 93.33
HRA- vs. LRC 80.0% (71.2–88.8%) 58.70 87.5 81.82 68.85
Temporal-Parietal
ASD vs. HRA− 76.9% (66.2–87.6%) 80 65.31 54.05 86.49
ASD vs. LRC 89.4% (81.3–97.4%) 90 75 60 94.74
HRA- vs. LRC 80.9% (72.6–89.2%) 83.67 68.52 70.69 82.22
3–36 months
Frontal
ASD vs. HRA− 86.7% (78.1–95.3%) 84 81.54 63.64 92.98
ASD vs. LRC 87.0% (77.2–96.8%) 84 80.65 63.64 92.59
HRA− vs. LRC 81.1% (73.8–88.4%) 72.31 74.19 74.6 71.88
Whole-head
ASD vs. HRA− 87.7% (79.5–95.9%) 84 84.62 67.74 93.22
ASD vs. LRC 85.7% (74.9–96.6%) 80 90.32 76.92 91.80
HRA− vs. LRC 77.5% (69.4–85.5%) 69.23 75.80 75 70.15
Temporal-Parietal
ASD vs. HRA− 83.6% (75.1–92.2%) 67.74 85.92 67.74 85.92
ASD vs. LRC 87.0% (77.5–96.6%) 84 83.87 67.74 92.86
HRA− vs. LRC 75.2% (66.8–83.7%) 72.31 72.58 73.44 71.43
†Evaluated at Youden’s index maximum
CI95 95% confidence interval around the estimate, PPV positive predictive value (true positive outcome percentage), NPV negative predictive value (true negative outcome percentage)
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t test p= 0.012, vs. LRC: interaction Student’s t test p= 0.042). Less
steep changes in gamma power from 3–36 months increased the
log-odds of the child having ASD across comparisons, over and
above the other selected frequency band parameters (vs. HRA−,
Student’s t test p= 0.031; vs. LRC: Student’s t test p= 0.028). A
significant interaction between summed power in the beta band at
6 months and the developmental slope in summed power in the
beta band over 3 years was a significant individual indicator of
Table 2 Frontal 3–12 months EEG power models
Parameters ASD vs. HRA− B coefficient (SE)
p value
ASD vs. LRC
B coefficient (SE) p value
HRA− vs. LRC
B coefficient (SE) p value
Model intercept −10.44 (5.91) 0.077 10.36 (6.64) 0.118 8.98 (2.43) 0.0002
Sex 1.23 (0.81) 0.129 – – – –
Parental Education 1 – – −0.99 (1.46) 0.498 −1.76 (0.95) 0.065
Parental Education 2 – – −3.34 (1.49) 0.025 −2.22 (0.87) 0.01
6-month Intercept
Delta −25.5 (12.59) 0.043 24.98 (15.62) 0.11 – –
Theta 20.4 (12.17) 0.094 −24.79 (15.01) 0.099 – –
Low Alpha 15.72 (7.71) 0.042 – – −5.85 (1.77) 0.001
High Alpha 9.93 (8.25) 0.229 17.78 (7.28) 0.015 – –
Beta −8.97 (5.75) 0.119 −19.25 (8.38) 0.022 – –
Gamma – – −2.91 (6.38) 0.648 – –
Slope 3–12 months
Delta – – 30.78 (11.11) 0.006 6.18 (2.69) 0.022
Theta 38 (18.07) 0.035 −8.31 (10.68) 0.436 −8.81 (3.02) 0.003
Low Alpha −26.02 (16.16) 0.107 – – – –
High Alpha 31.6 (18.45) 0.087 – – – –
Beta −29.73 (17.57) 0.091 – – – –
Gamma 5.66 (3.85) 0.142 −17.39 (9.71) 0.073 – –
Intercept × Slope
Delta – – – – – –
Theta −22.43 (12.71) 0.078 −18.86 (7.57) 0.013 – –
Low Alpha 21.74 (11.75) 0.064 – – – –
High Alpha −35.59 (17.32) 0.04 – – – –
Beta 18.39 (11.7) 0.116 – – – –
Gamma – – 13.62 (8.59) 0.113 – –
SE standard error; bold values indicate statistically significant parameters (determined by Student’s t test) within each model at the level of p < 0.05
Table 3 Frontal 12–24 months EEG power models
Parameters ASD vs. HRA− B coefficient (SE)
p value
ASD vs. LRC
B coefficient (SE) p value
HRA- vs. LRC
B coefficient (SE) p value
Model intercept −14.98 (5.69) 0.008 21.12 (7.69) 0.006 11.94 (3.13) 0.0001
Sex – – 1.6 (0.84) 0.056 – –
Parental Education 1 – – −2.02 (1.55) 0.193 – –
Parental Education 2 – – −3.21 (1.38) 0.02 – –
12-month Intercept
Delta 22.49 (9.32) 0.016 −10.34 (6.5) 0.112 – –
Theta −23.93 (9.56) 0.012 – – – –
Low Alpha 11.17 (5.59) 0.046 – – – –
High Alpha – – 13.69 (7.77) 0.078 −9.71 (2.54) 0.0001
Beta −0.19 (2.85) 0.946 −14.19 (5.88) 0.016 – –
Gamma – – – – – –
Slope 12–24 months
Delta −13.59 (8.68) 0.117 −37.42 (16.06) 0.02 – –
Theta – – – – – –
Low Alpha 6.15 (3.78) 0.104 – – – –
High Alpha −10 (4.8) 0.037 – – −9.37 (3.66) 0.01
Beta 31.54 (11.98) 0.008 – – – –
Gamma – – – – – –
Intercept × Slope
Delta 9.89 (6.2) 0.111 26.59 (11.74) 0.024 – –
Theta – – – – – –
Low Alpha – – – – – –
High Alpha – – – – 4.49 (3.17) 0.156
Beta −15.93 (7.46) 0.033 – – – –
Gamma – – – – – –
SE standard error; bold values indicate statistically significant parameters (determined by Student’s t test) within each model at the level of p < 0.05
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high-ASD risk relative to LRC status (ASD: Student’s t test p=
0.013, HRA−: Student’s t test p= 0.012).
Discussion
One major unresolved goal in ASD research is the identification
of early biomarkers that reveal the underlying pathophysiology
differentiating subsequent diagnostic outcomes8. To address this
challenge, we leveraged longitudinal baseline EEG across the first
3 years post-birth from the largest electrophysiological study of
infants at low- and high-familial risk for ASD to date. We
identified EEG power parameters across key developmental
windows that distinguished risk and subsequent diagnostic out-
comes with high fidelity. These findings provide evidence that
EEG power measures constitute highly informative candidate
biomarkers in the following ways.
This is the first study of potential neurophysiological bio-
markers in ASD to assess diagnostic differentiation across ages
within the same infants. Our findings comparing EEG power
measures taken across multiple developmental windows and
spatial configurations indicate that frontal EEG power within the
first year after birth best discriminates ASD outcomes. EEG
power closer to the age of diagnosis (when behavioral symptoms
are evident) did not provide additional utility for differentiating
outcomes, and instead showed diminished specificity and capa-
city to detect true ASD diagnoses at optimized thresholds. That is,
the capacity of the EEG power measures studied here to classify
ASD as a homogenous outcome appears to wane as the capacity
of behavioral measures to do so grows20. Notably, although the
prevalence of ASD differs between males and females, sex was not
a significant predictor in any of the frontal EEG models, sug-
gesting the information provided by the EEG parameters was
more useful in differentiating ASD outcomes. Moreover, the
results differentiating between the high- and low-ASD risk groups
in the absence of ASD suggest that early frontal EEG power is
sensitive enough to differentiate subclinical changes in brain
function as well21. This capacity to differentiate between risk
groups did improve over the 3 years of EEG measurements,
suggesting subclinical differences may emerge more gradually or
at a later time than differences in the high-risk infants with future
ASD diagnoses.
Our findings also indicate that the spatial localization of EEG
power measurements matters in distinguishing outcomes. The a
priori clustered frontal EEG region of interest and a clustered
temporal-parietal layout examined in supplemental analyses both
provided better differentiation than the averaged 10–20 standard
layout in the first postnatal year, suggesting sparse electrode
configurations like those used in clinical settings currently may
not provide the optimal layout for measuring early EEG bio-
markers of ASD. The more densely clustered EEG layouts may
have benefited from a higher signal-to-noise ratio than the whole-
head layout. Notably, the frontal region of interest also provided
better differentiation in the first year than the clustered temporal-
parietal region, suggesting the spatial specificity of the EEG power
measures is important for discriminating groups. At later devel-
opmental windows, the densely clustered and whole-head con-
figurations offered different strengths, such that the frontal and
temporal-parietal layouts largely achieved higher sensitivity rates,
while the whole-head layout had largely higher specificity rates.
Thus, both the spatial location and the spatial density of EEG
channels are important factors to consider in EEG-derived bio-
marker development to differentiate ASD outcomes, especially
early in postnatal development.
Our data-driven modeling approach to identify pathophysiol-
ogy highlights the importance of characterizing the longitudinal
development of candidate biomarkers in several ways. First, this
approach selected the most parsimonious set of parameters that
differentiated groups within each developmental window, allow-
ing us to examine whether the most robust EEG power dis-
criminators changed as a function of age. For example, differences
in EEG power observed in the first year may persist but may no
Table 4 Frontal 3–36 months EEG power models
Parameters ASD vs. HRA− B coefficient (SE)
p value
ASD vs. LRC
B coefficient (SE) p value
HRA- vs. LRC
B coefficient (SE) p value
Model intercept −11.27 (4.25) 0.008 0.47 (7.39) 0.95 11.03 (3.43) 0.001
Sex 1.05 (1.05) 0.138 – – – –
Parental Education 1 1.29 (0.92) 0.162 −1.4 (1.27) 1.27 −1.78 (0.86) 0.038
Parental Education 2 −0.62 (0.85) 0.465 −2.72 (1.24) 0.028 −2.06 (0.76) 0.007
6-month Intercept
Delta 8.17 (10.9) 0.454 11.99 (13.91) 0.389 – –
Theta 9.44 (12.22) 0.44 −15.63 (15.82) 0.323 −1.83 (3.21) 0.57
Low Alpha −16.48 (6.75) 0.015 7.71 (8.9) 0.386 – –
High Alpha 16.46 (5.77) 0.004 2.16 (11.64) 0.852 −5.36 (4.35) 0.218
Beta – – 0.68 (8.45) 0.936 −1.44 (3.01) 0.633
Gamma −7.34 (3.34) 0.028 −7.77 (5.88) 0.186 – –
Slope 3–36 months
Delta 74.03 (74.03) 0.031 83.66 (50.61) 0.098 9.35 (5.64) 0.097
Theta −39.15 (−39.15) 0.221 −121.48 (65.78) 0.065 17.9 (13.17) 0.174
Low Alpha −20.6 (8.2) 0.012 74.56 (37.72) 0.048 – –
High Alpha – – −59.94 (44.13) 0.174 −25.01 (13.67) 0.067
Beta 7.4 (5.34) 0.166 71.93 (29.12) 0.014 36.07 (14.95) 0.016
Gamma −10.64 (4.92) 0.031 −24.7 (11.23) 0.028 – –
Intercept × Slope
Delta −56.39 (26.88) 0.036 −54.61 (37.77) 0.148 – –
Theta 56.61 (27.9) 0.042 95.13 (52.8) 0.072 −23.54 (9.97) 0.018
Low Alpha – – −55.91 (27.5) 0.042 – –
High Alpha – – 47.25 (36.4) 0.194 25.74 (13.33) 0.053
Beta – – −46.04 (18.58) 0.013 −28.13 (11.16) 0.012
Gamma – – 15.94 (8.79) 0.07 – –
SE standard error; bold values indicate statistically significant parameters (determined by Student’s t test) within each model at the level of p < 0.05
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longer be the most robust discriminators in later developmental
windows as other developmental dynamics emerge, including
adaptive and compensatory changes. Indeed, across timescales
from 12 months to 3 years, we observed developmental changes
in which parameters provided the best differentiation. Though
early emerging differences largely remained robust discriminators
at later ages, we also noted a general shift from significant low
frequency predictors across the first year toward additional sig-
nificant higher frequency predictors across the second and third
years. This delay in high-frequency candidate biomarkers show-
ing robust differentiation recapitulates maturation patterns of
EEG power spectra observed in prior studies during this same
period22.
In addition, our findings show that both EEG power in early
infancy and subsequent developmental changes in power over
months and years are critical pathophysiological features distin-
guishing ASD outcomes. Although prior studies have largely
focused on evaluating candidate biomarkers at single timepoints,
the data-driven selection of slope parameters in our models
demonstrates that developmental trajectories themselves are robust
potential biomarkers. This result adds to emerging evidence across
modalities that developmental trajectories may be more informa-
tive features for distinguishing ASD outcomes than single time-
point measures17,18,23. These EEG power developmental slope
parameters also present robust biological opportunities for future
interventions to target and alter the developmental course of ASD.
Importantly, we identified the EEG power pathophysiology
during each developmental window that best differentiates ASD
risk and subsequent ASD outcomes in our sample. As we tested
for the combination of EEG power variables that together could
distinguish groups, the set of power parameters included in each
data-driven model constitutes the candidate biomarker for that
developmental window. Almost all models included power
parameters from multiple frequency bands, suggesting the pattern
of power across bands facilitates better differentiation of risk and
outcome groups than parameters in any single frequency band.
These results are consistent with Wang and colleagues’ synthesis
across studies of baseline EEG power suggesting that an atypical
distribution of power across the spectrum distinguishes indivi-
duals with ASD from neurotypical individuals24. Accordingly,
recent interventions seeking to modulate frontal EEG power in
those with ASD have assessed patterns of change across the power
spectrum as the biological target25. Evaluating multiple EEG
frequency bands simultaneously may thus facilitate both efforts to
differentiate outcomes and to leverage EEG power in interven-
tions at the physiological level.
Across models, we also identified trends for specific EEG fre-
quency bands that significantly contributed to group differ-
entiation and may reflect physiological mechanisms altered in
ASD development. We found that developmental changes in low-
frequency power stratified both ASD risk status and diagnostic
outcome. Specifically, we found that steeper rates of increase in
summed power in the delta band across the first 12 months
differentiated high-risk (regardless of diagnosis) from the low-risk
status infants. Further changes in delta power over the next 2
years contributed to ASD outcome differentiation within the
high-risk infants. Infants with subsequent ASD diagnoses had
steeper rates of increase in summed delta power before age 3
years. Prior research has similarly noted low frequency power
differences in children with ASD26,27. Activity in low frequency
bands, including delta, has been shown to stimulate inhibition
(i.e., activity suppression) in brain circuits28. Insufficient neural
inhibition levels have been posited in ASD, and the increase in
summed delta power observed in the high-risk infants may reflect
an early compensatory mechanism to modulate excessive exci-
tation levels and restore the balance of neural excitation and
inhibition29,30. Further research is needed to clarify the role that
delta power modulation plays as a risk or resilience factor in ASD
development.
We also found that across comparisons in the first three years,
summed power in the gamma frequency band uniquely dis-
tinguished children with ASD relative to others. The high-risk
infants who later received an ASD diagnosis demonstrated lower
frontal gamma power at age 6 months and a lower rate of increase
through age 3 years compared to the other groups. Prior work has
identified similar gamma differences in ASD populations31,32, and
here for the first time we show that gamma changes differentiate
diagnostic outcome. Notably, gamma power reflects the balance of
excitation and inhibition within brain circuits that regulates neu-
roplasticity and experience-dependent development30,33. Lower
gamma power in infants who are later diagnosed is consistent with
insufficient neural inhibition and atypical neuroplasticity in
ASD34,35. Moreover, gamma power has been associated with the
development of language skills, an experience-dependent process
that is often delayed and impaired in ASD36,37. Therefore, lower
frontal summed gamma power during infancy in individuals with
ASD may reflect core underlying neuroplasticity changes and
portend emerging language impairments.
It is important to acknowledge several limitations of the cur-
rent study within the context of biomarker development and
validation. Here, we have identified candidate EEG power bio-
markers across multiple developmental windows and spatial
configurations, so further research is now required to evaluate the
reliability, disorder specificity, and external validity of these
measures. We chose to examine baseline EEG power measures as
candidate biomarkers in part because baseline EEG power has
previously demonstrated high test–retest reliability (Cronbach’s
alpha estimates of 0.90 and higher) across multiple time scales
(within session, across days) in both typically developing children
and clinical populations, including ASD (e.g., 38–42). Prior studies
have shown that 40–60 s of clean EEG data is sufficient to achieve
such high levels of reliability in absolute power estimates across
the scalp39,40. Therefore, in the present study, we required infants
to contribute at least 40 s of clean EEG data for analyses to
increase the reliability of our model estimates. Future research
conducting test–retest analyses of EEG power measures within-
participants across consecutive days in infancy is needed to
confirm that the high reliability of these EEG power measures
extends to the first postnatal months of age.
Second, further testing across clinical populations is required to
determine the specificity of these EEG power candidate bio-
markers. The present study could not disentangle whether the
EEG power parameters differentiating the infants with ASD were
specific to the familial-risk group or would generalize to other
ASD-risk groups. In addition, the candidate biomarkers we
identified may reflect disruptions in processes affected in other
neurodevelopmental disorders as well (e.g., language acquisi-
tion11). However, infants with high-familial risk who are not
diagnosed with ASD frequently manifest subclinical and clinical
disruptions in the same domains as the high-risk infants with
ASD, and develop other disorders at elevated rates21,43–47. The
candidate biomarkers we identified distinguishing the high-risk
infants with and without ASD achieved very high levels of
accuracy, though, suggesting some specificity for ASD diagnosis
in the present study. Additional research across ASD-risk and
neurodevelopmental disorder-risk populations is needed to con-
firm the diagnostic specificity of these EEG power measures
before they may be used as diagnostic biomarkers.
Lastly, further research is required to assess the external
validity of the candidate biomarkers identified in the present
analyses. While this study had a greater number of infant siblings
with ASD diagnoses relative to prior reports, the present sample
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is still limited, so these findings should be replicated with larger
samples in future research. We were well powered to achieve the
study’s primary goal of evaluating model performance within our
longitudinal sample across different developmental windows, but
our sample size prevented us from validating model performance
in out-of-sample sets (e.g., split-half training and testing sets).
In addition, the study’s over-recruitment of high-risk infants is
a strength, but the ratio of high-risk to low-risk infants is
therefore not representative of the general population. So, the
positive and negative predictive values (NPV) for models com-
paring these groups may be different in the general population.
Future research testing the external validity of these power
measures should also examine how robust the patterns identified
here are across EEG acquisition equipment and parameters. To
facilitate this type of future assessment, here we used a brief,
naturalistic baseline paradigm, as collecting several minutes of
EEG at baseline may prove more scalable than collecting event-
related EEG, and we used standardized, open-source processing
software that we developed for use across various EEG systems
and files with different acquisition parameters.
This study sought to provide the pathophysiological course of
EEG power that distinguishes ASD outcomes. Our longitudinal
approach highlights the importance of developmental timing and
the significant role of neurodevelopmental change in classifying
disorder outcomes. Taken together, these findings demonstrate
great promise for EEG power measures in the first year post-
natally as candidate biomarkers in ASD.
Methods
Participants. Participants in the present study were part of a prospective, long-
itudinal investigation across the first 3 postnatal years of infants at high- and low-
familial risk for ASD. Institutional review board (IRB) (i.e., the ethics regulatory
committee in the USA) approval was obtained from Boston University and Boston
Children’s Hospital (IRB # X06-08-0374) prior to the start of the study. Written,
informed consent was obtained from a parent or guardian prior to each infant’s
participation in the study.
Infants were designated high-risk for autism (HRA) if they had at least one
older sibling with a community diagnosis of ASD that could not be attributed to a
known genetic disorder (e.g., Fragile X syndrome). Infants were designated low-risk
for autism controls (LRC) if they had a typically developing older sibling and no
first- or second-degree family members with ASD. All infants included in the study
had a gestational age of at least 36 weeks, no known prenatal or postnatal medical
or neurological complications, and no known genetic disorders (e.g., Fragile X
Syndrome, Tuberous Sclerosis Complex).
Final ASD outcomes were determined for all infants using the Autism
Diagnostic Observation Schedule (ADOS) in conjunction with clinical best
estimate. For children meeting criteria on the ADOS, or coming within three points
of cutoffs, a Licensed Clinical Psychologist reviewed scores and video recordings of
concurrent and previous behavioral assessments, and using DSM-V criteria
provided a best estimate clinical judgment: typically developing, ASD, or non-
spectrum disorder (e.g., ADHD, anxiety, and language concerns). By 36 months of
age we identified three groups of infants: HRA infants with ASD (ASD), HRA
infants without ASD (HRA−), and LRC infants without ASD (LRC). Of the 102
HRA infants contributing data for this study, 4 children had final outcome
judgments at 18 months (1 ASD and 3 HRA−), 15 children had final outcome
judgments at 24 months (3 ASD and 12 HRA−), and 83 children had final
outcome judgments at 36 months (27 ASD and 56 HRA−). The 3 HRA children
with HRA- outcomes determined at 18 months of age all had ADOS calibrated
severity scores of 1 (minimal to no evidence of ASD), and were not statistical
outliers within their HRA- group on any EEG power measure, so they were
retained in analyses. Across outcome visits, 31 HRA children met criteria for ASD
(ASD outcome group) and 71 were classified as no ASD (HRA− outcome group).
None of the 69 LRC infants contributing data met criteria for ASD at outcome
visits. The demographic composition of each outcome group is presented in
Table 5. The ASD group had significantly more male children than the HRA−
group (Pearson X2 (1, 102)= 4.64, p= 0.031. The LRC group had higher mean
parental education level than both the ASD group (Pearson X2 (2, 87)= 12.65, p=
0.002) and the HRA− group (Pearson X2 (2, 127)= 6.62, p= 0.036). Accordingly,
sex and parental education parameters were included as potential covariates during
model selection to ensure the EEG parameters explained the variance in outcome
status unrelated to these demographic parameters. Supplemental analyses were also
performed without the sex and education parameters as potential covariates, and
results were highly consistent with the reported results.
EEG data were collected when infants were 3, 6, 9, 12, 18, 24, and 36 months of
age. Not all infants contributed adequate EEG data at all timepoints. The sample
size of usable EEG for each outcome group at each timepoint, sample sizes for each
of the primary analyses run across timepoints, and the mean number of EEG
recordings that each participant within each outcome group contributed to primary
analyses are provided in Table 5. Across outcome groups, comparable numbers of
EEG recordings were contributed per participant. For primary analyses (3–12,
12–24, and 3–36 months) the mean number of EEG recordings contributed per
participant did not significantly differ between pairs of outcome groups in 8 of the
9 comparisons (only LRC and HRA− groups in the 3–36 month analysis
significantly differed, with LRC infants contributing more EEGs [Student’s t
(138)= 2.35, p= 0.02]). In addition, the number of EEG recordings contributed
per participant did not appreciably impact the EEG power estimates derived from
the longitudinal data (p > 0.05 in 35 of 36 Pearson’s correlations between number
of EEG recordings per participant and participants’ EEG power parameters in
primary analyses over frontal cortex; number of recordings was weakly associated
with theta band 12-month power in the 12–24 month frontal analysis only
[Pearson’s correlation r= 0.183, p= 0.045]).
Table 5 Sample demographics
Low-risk
control
n= 69
High-risk
No ASD
n= 71
High-risk
ASD
n= 31
Sex 37 M, 32 F 34 M, 37 F 22 M, 9 F
Child ethnicity (%)
Caucasian 85.5 93.0 80.6
Hispanic/Latinx 1.4 4.2 16.1
Asian American 2.9 2.8 6.5
African American 1.4 1.4 0
Multirace 8.7 2.8 12.9
Mean household income
($1000 s)
65–75 65–75 65–75
Mean parental education (%)
<4 year college 4.3 16.9 19.4
=4 year college 16.0 19.7 29.0
>4 year college 70.0 54.9 32.3
Included EEG data
By visit age (n)
3 months 10 15 9
6 months 51 39 15
9 months 55 49 21
12 months 61 45 26
18 months 45 48 22
24 months 46 48 20
36 months 49 45 16
By analysis (n)
3–12 months 63 51 22
12–24 months 54 48 25
3–36 months 69 71 31
In all analyses 52 38 20
By participant (mean number of EEG recordings [SD])
3–12 months analysis 2.7 (0.64) 2.6 (0.64) 2.9 (0.77)
12–24 months analysis 2.5 (0.50) 2.5 (0.51) 2.4 (0.49)
3–36 months analysis 4.6 (1.22) 4.1 (1.39) 4.2 (1.55)
Included EEG HAPPE metrics (mean [SD] range)
Length of raw EEG
(seconds)
169.8 (94.3)
44–784
182.9 (128)
44–1067
191.1 (105)
64–594
Good channels (%) 91.9 (4.5)
82.1–100
92.9 (4.5)
82.1–100
91.9 (4.3)
82.1–100
Rejected
components (%)
41.3 (11.8)
0–68.8
42.0 (12.7)
5.1–74.3
38.9 (15.0)
0–72.2
EEG variance
retained (%)
63.6 (14.9)
32.1–100
63.7 (15.3)
33.6–98.1
68.3 (14.5)
39–100
Mean retained artifact
probability
0.16 (0.05)
0.03–0.30
0.17 (0.04)
0.047–0.28
0.16 (0.05)
0.047–0.25
Median retained artifact
probability
0.13 (0.08)
0.01–0.34
0.13 (0.06)
0.01–0.31
0.12 (0.06)
0.01–0.25
EEG segments retained
(n)
74.6 (40.7)
21–334
81.0 (54.7)
21–474
84.3 (46.5)
31–260
SD standard deviation
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EEG data acquisition. Baseline, resting EEG data were acquired while the infants
were seated on their caregivers’ laps in a dimly lit, sound-attenuated, electrically
shielded room. Continuous EEG was recorded for between approximately 2 and
5 min. A research assistant sat to the side of the caregiver and infant. They were in
the room to assist in keeping the infant calm and still by blowing bubbles across the
room or presenting a quiet toy to the infant if they became fussy (e.g., a ball).
Research assistants did not engage the infants in social interaction. This EEG
collection environment follows both standard empirical study conditions for
baseline EEG collection (e.g., 48 and serves as a scalable, naturalistic EEG paradigm
that can translate to clinical settings. EEG data were collected with Geodesic Sensor
Nets, using a 0.1 Hz high-pass analog (i.e., hardware) filter and online rereferencing
to the vertex (channel Cz) through NetStation software (Electrical Geodesics, Inc
(EGI), Eugene, OR, USA). Impedances were kept below 100KΩ in accordance with
the impedance capabilities of the high-impedance amplifiers inside the electrically
shielded room49.
EEG processing. The continuous, baseline EEG data were first exported from
NetStation native format to MATLAB format (R2017a). Data preprocessing, arti-
fact removal, and data quality assessment was carried out via the Harvard Auto-
mated Processing Pipeline for EEG (HAPPE), a preprocessing pipeline optimized
for developmental EEG data50. HAPPE has been shown to reject more artifacts and
simultaneously preserve more EEG signal during processing than other
contemporary EEG processing approaches, including manual editing50. All files
were batch processed using the batch electroencephalography automated proces-
sing platform (BEAPP) software, allowing for the same empirical criteria for
artifact removal to be applied to each file in the same way51. To optimize artifact
rejection performance given the lengths and sampling rates in the EEG data, a
spatially distributed subset of channels providing whole-head coverage was pro-
cessed through HAPPE (64-channel net—2, 3, 6, 8, 9, 11, 12, 13, 15, 16, 17, 21, 24,
25, 27, 28, 34, 37, 40, 46, 49, 50, 52, 53, 54, 57, 58, 61, 62; 128-channel net—3, 4, 9,
11, 13, 19, 20, 22, 23, 24, 27, 28, 33, 36, 40, 41, 45, 46, 47, 52, 58, 62, 70, 75, 83, 92,
96, 98, 102, 103, 104, 108, 109, 112, 117, 118, 122, 123, 124; Supplementary Fig. 1).
For each EEG, a 1 Hz digital high-pass filter and a 100 Hz low-pass filter was
applied in preparation for independent component analysis52. Data sampled at 500
Hz were then resampled with interpolation to 250 Hz as recommended for HAPPE
processing (resampling was performed after filtering to avoid aliasing higher fre-
quencies when resampling). HAPPE’s artifact removal steps included removal of
60 Hz electrical noise through CleanLine’s multi-taper approach53, bad channel
rejection, and participant artifact rejection (e.g., eye blinks, movement, and muscle
activity) through wavelet-enhanced ICA with automated component rejection via
EEGLAB54,55 and the Multiple Artifact Rejection Algorithm56. Post-artifact
rejection, any channels removed during the bad channel rejection were repopulated
through spherical interpolation to reduce spatial bias in rereferencing. The EEG
data were then rereferenced to the average reference and mean signal detrended.
The EEG was segmented into contiguous 2-s windows and any segments with
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Fig. 2 Analysis schematic. Conceptual diagram illustrating how longitudinal EEG parameters were generated and analyzed. a (For each participant): at
every age, the total, summed power in each canonical frequency band (delta, theta, low alpha, high alpha, beta, gamma labeled with their Greek symbol
equivalents) was calculated as the area under the curve of the EEG power distribution (left panel). Growth trajectories of summed power in each frequency
band were generated across (1) 3–12, (2) 12–24, and (3) 3–36 postnatal months of age (beta frequency band 3–36 month trajectories plotted here, middle
panel). Growth trajectories of summed power from each frequency band were linearized by modeling log (summed power) as a function of log (age) for
each frequency band; this allowed for the calculation of an estimated intercept (here, at 6 months) and a linear developmental slope for each individual
with at least two EEG recordings to be submitted to group-level analysis (right panel, here for beta frequency band). b (Group-level effects): three types of
effects were tested for in the data-driven model construction to differentiate all pairs of groups (here, the low-risk control (LRC, in green color) vs. Autism
(ASD, in blue color) group comparison is shown): main effects of differences in intercepts (left panel), and developmental slopes (middle panel), and
interaction effects between intercept and slope (right panel). The interaction effect tested whether the relation between intercept and slope varied between
groups (e.g., here, individuals in the ASD group have the same slope regardless of having low or high intercept values, but individuals in the LRC group have
steeper slope values with higher intercept values)
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retained artifact were rejected using HAPPE’s amplitude and joint probability
criteria, as in prior research with developmental EEG57. Noncontiguous data were
not concatenated during this process. Importantly, outcome groups did not sig-
nificantly differ in the mean lengths of their processed EEG or in any of the HAPE
data quality measures (all Student’s t test p > 0.05, Table 5).
EEG rejection criteria. Standard HAPPE processing includes the application of
recommended thresholds to HAPPE data quality metrics to identify and reject
problematic EEG files postautomated processing. These quantitative file quality
thresholds together with the automated data rejection procedures within HAPPE
facilitate reproducible analyses. EEGs were rejected if they had fewer than 20
postprocessed good segments (40 total seconds of EEG) in keeping with recom-
mendations for achieving highly reliable EEG power estimates39,40, or were more
than 3 standard deviations (SD) from the mean on the following HAPPE metrics:
percent good channels (3SD: <82%), mean retained artifact probability (3SD: >0.3;
the estimated probability that retained independent components contain any
artifact, calculated as an intermediate processing metric before further segment
rejection based on remaining artifact), median retained artifact probability (3 SD:
>0.35; the median value for the same artifact probability metric as the mean
values), percent of independent components rejected as artifact (3SD: >84%), and
percent of EEG signal variance retained after artifact removal (3SD: <32%). EEGs
with a mean power greater or less than two SD from their outcome group for each
frequency band were visually reviewed blind to outcome group status. This led to
the rejection of 25 additional EEG recordings (9 LRC EEGs, 11 HRA- EEGs, and 5
ASD EEGs) out of 760 recordings (3% of recordings) and only 1 participant to be
dropped from analysis. HAPPE quality metrics and visual inspection rejection rates
did not significantly differ between any pair of outcome groups (all Student’s t test
p > 0.1, Table 5). Supplemental Pearson correlation analyses assessed whether the
lengths of either the raw or post-HAPPE processed EEG files were associated with
the amount of artifact in the data (measured directly by the percent of independent
components rejected and the percent of variance retained after artifact removal).
There were no significant associations between the average lengths of the raw or
processed EEG per participant and the amount of artifact detected in the EEG data
across the 3–12, 12–24, or 3–36 month analyses (all Pearson’s correlation p > 0.10).
EEG power decomposition. A Fast Fourier Transform with multitaper windowing
(3 tapers) was used to decompose the EEG signal into power for each 2-s segment
for each of the channels of interest. Two nets (64-channel and 128-channel) were
used across the course of the longitudinal study (the switch from 64- to 128-
channel nets occurred because the company ceased supporting the 64-channel net
equipment), so channels were selected for analysis from spatial locations that
corresponded across nets (EGI, Eugene, OR). Channels clustered over the frontal
cortex were analyzed in primary analyses (64-channel net—2, 3, 8, 9, 12, 13, 58, 62;
128-channel net—3, 4, 11, 19, 20, 23, 24, 27, 118, 123, 124; Supplementary Fig. 1).
Supplemental analyses were performed to compare the results from the a priori
selected frontal cortex region of interest with both a distributed, standard layout
and an additional clustered region of interest. These supplemental layouts consisted
of HAPPE’s whole-head 10–20 channel equivalents (64-channel net—3 (Fz), 13
(F3), 62 (F4), 15 (F7), 61 (F8), 17 (C3), 54 (C4), 24 (T3), 52 (T4), 27 (T5), 49 (T6),
28 (P3), 34 (Pz), 46 (P4), 37 (O1), 40 (O2); 128-channel net—11 (Fz), 24 (F3), 124
(F4), 33 (F7), 122 (F8), 36 (C3), 104 (C4), 45 (T3), 108 (T4), 58 (T5), 96 (T6), 52
(P3), 62 (Pz), 92 (P4), 70 (O1), 83 (O2)), and channels clustered over bilateral
temporal-parietal cortex (64-channel net—21, 24, 25, 28, 46, 50, 52, 53; 128-
channel net—40, 41, 45, 46, 47, 52, 92, 98, 102, 103, 108, 109).
For each of the six frequency bands typically used in infant EEG studies, the
summed power across all frequencies within the band was calculated as the
measure of total power in that frequency band (i.e., power density, or power/Hz
was not used in these analyses. Here, summed power in a frequency band is
equivalent to the area under the power density curve for that frequency band;
Fig. 2). Frequency bands were defined as follows: delta, 2–3.99 Hz; theta, 4–5.99 Hz;
low alpha, 6–8.99 Hz; high alpha, 9–12.99 Hz; beta, 13–29.99 Hz; gamma, 30–50
Hz. For each EEG recording and each channel, the average summed power in each
frequency band across all 2-second segments was calculated and normalized by a
log base 10 transform. For each EEG recording, the summed power in each
frequency band was then averaged across all channels of interest. (See Fig. 3 for the
mean EEG summed power in each frequency band at each timepoint for the frontal
configuration used in the primary analyses).
Longitudinal EEG power parameters (within-participant). Within-participant
analyses were carried out in SAS software. To reduce the number of EEG para-
meters tested in the primary statistical analyses differentiating outcome and risk
groups, the trajectories of EEG summed power within each frequency band across
development were summarized by two parameters per frequency band: EEG
summed power intercepts and the slope of EEG summed power across age
(developmental slope; Fig. 2). To generate these parameters, we ran ordinary least
squares (OLS) regressions for each infant, modeling that infant’s age-related
change in EEG summed power within each frequency band. The OLS regressions
modeled log-transformed EEG summed power as a function of log visit age, given
the nonlinear, logarithmic age-related changes in log-transformed EEG summed
Frontal electrodes
Delta Theta Low alpha
GammaBeta
Visit age (months)
High alpha
1.4 1.3
1.5
1.4
1.3
1.2
1.1
1.0
0.9
0.8
0.7
1.2
1.1
1.0
0.9
0.8
1.3
1.2
1.1
1.0
0.9
0.6
3 3 36 6 69 9 912 12 1218 18 1824 24 2436 36 36
LR
HR-NoASD
HR-ASD0.7
0.8
0.9
1.0
1.1
1.2
1.3 1.6 1.3
1.2
1.1
1.0
0.9
0.8
0.7
1.5
1.4
1.3
1.2
1.1
1.0
0.9
Lo
g 
10
 tr
a
n
sf
o
rm
e
d 
po
w
e
r 
(μV
2 )
Lo
g 
10
 tr
a
n
sf
o
rm
e
d 
po
w
e
r 
(μV
2 )
Fig. 3 EEG power from 3 to 36 months of age. Mean log of EEG power, calculated as the sum of the power across each frequency band, is shown for each
frequency band over all visit ages for each outcome group, low-risk control (LRC, represented by green circles), high-risk without Autism (HRA−,
represented by orange letter x), and high-risk with Autism (ASD, represented by blue squares) for the frontal region of interest. Lines connecting power
values across visit ages are to aid visualization. Error bars are 95% confidence intervals around the mean
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-12202-9
10 NATURE COMMUNICATIONS |         (2019) 10:4188 | https://doi.org/10.1038/s41467-019-12202-9 | www.nature.com/naturecommunications
power observed across outcome groups and frequency bands. Modeling log-EEG
summed power as a function of log-age linearized the relation between EEG and
age (i.e., a linear regression line could be fit between these log-transformed vari-
ables). Infants therefore needed EEG recordings from only two visits to calculate
this linear regression line, and contribute data to between-participant analyses.
Individual OLS regressions were run using all available data for each infant
across three different age ranges: 3–12, 12–24, and 3–36 months of age. The 12-
month time point was included in both the 3–12 and 12–24 month windows to
maximize the sample size of infants contributing to both sets of analyses, and to
facilitate more complete coverage of the first and second postnatal years in each
respective analysis.
For each developmental window, participants’ OLS regression equations were
used to generate their individual summed power intercept and linear
developmental slope values in each frequency band for between-participant
analyses. For the summed power intercept values in the 3–12 and 3–36 month
analyses, the estimated summed power at 6-months of age was calculated from the
fitted regression equation for each infant (including infants who had 3-month
data). We chose the estimated summed power at 6 months of age rather than
3 months of age for the initial value so we could more easily compare trends at 6-
months of age to prior studies whose earliest timepoint was 6 months of age, and
because more infants across all risk and outcome groups contributed EEG data at
the 6-month timepoint than at the 3-month timepoint (which was added later in
the study). In the 12–24 month EEG analyses, 12 months was used for the EEG
summed power intercepts for all infants. EEG summed power developmental
slopes were calculated as the linear slope parameter estimates from the OLS
regression model over each developmental window.
Statistical software. All analyses were carried out in R software58. All reported
statistical tests in the present study are two-sided tests wherever applicable.
Data-driven model construction. Potential predictors of interest included the
EEG summed power intercepts, the EEG summed power developmental slopes,
and parameters modeling the interaction terms between the intercept and slope
within each frequency band for the entire set of frequency bands (18 total para-
meters; Fig. 2). Given that child sex and parental education differed between
groups, these two variables were also entered as potential predictors to ensure that
the EEG parameters were differentiating outcome groups over and above the group
differences in sex and parental education.
Binary logistic regression models were constructed to understand the predictive
capabilities of EEG parameters adjusting for sex and parental education. Model
selection was carried out with a hybrid stepwise selection approach (i.e., data-
driven) by minimizing the Akaike Information Criteria (AIC). AIC provides a
relative estimate of a model’s out-of-sample predictive accuracy, where lower AIC
values indicate more accurate models (that is, AIC penalizes over-fitting to the
current sample)59–62. However, for sparse data, like the ASD group in the present
study, AIC is a pragmatic method to avoid parsing small samples60,63. Here, AIC
was used to identify the most accurate, generalizable model generated by the data
that differentiated outcome groups without overfitting to the present sample59.
Primary analyses modeled three group comparisons separately as these are not
collectively exhaustive categories: the ASD vs. HRA− groups, the ASD vs. LRC
groups, and the HRA− vs. LRC groups. Binary logistic regression models were
each constructed using (a) the EEG data measured between 3 and 12 months, (b)
EEG data measured between 12 and 24 months, and (c) EEG data from 3 to
36 months. Once the data-driven model selection process was completed, post hoc
hypothesis testing (Student’s t-tests on parameter estimates within the multiple
logistic regression) was performed to identify the relatively robust parameters that
differentiated outcomes in each model.
Model comparison criteria. To compare the AIC-minimized logistic regression
models’ performances across developmental windows and between group com-
parisons, in-sample receiver-operating characteristic (ROC) curve criteria were
used64. First, to compare how accurately the logistic models differentiated between
outcome groups, the area under the ROC curve (AUC) was calculated for each
model with bootstrapped 95% confidence intervals. The AUC metric is robust
under conditions of skewed sample sizes between groups, as in these data. The
sensitivity and specificity of the models were then evaluated using the threshold
that maximized Youden’s Index (i.e., Youden’s J statistic) to optimize the model’s
combined sensitivity and specificity rates65. To assess the true positive and true
negative differentiation rates across models, we calculated the PPV and NPV,
respectively at the threshold corresponding to Youden’s Index. These predictive
values account for the skewed disorder prevalence in the sample64.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The datasets analyzed during the current study are available from the corresponding
author on reasonable request.
Code availability
The statistical analysis code used during the current study is available from the
corresponding author on reasonable request. The code to process the EEG data is freely
available under the HAPPE and BEAPP software licenses (HAPPE: https://github.com/
lcnhappe/happe; BEAPP: https://github.com/lcnbeapp/beapp).
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